http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104017066-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104017066-B |
| titleOfInvention | One section of polypeptide with obvious analgesic activity |
| abstract | The invention discloses one section of polypeptide with obvious analgesic activity, belong to polypeptide.This polypeptide can apply to neuropathic pain analgesia.The method screening this peptide fragment and the application in neuropathic pain eases pain thereof are provided.Described peptide fragment may interfere with neuropathic pain (chronic constriction injury, CCI) mice anterior cingutate (anterior cingulate cortex, ACC) caveolin-1 (Caveolin 1, Cav 1) with N methyl D aspartate receptor 2B subunit (N Methyl D aspartate receptor2B subunit, NMDA NR2B) interact mediation pain and play analgesic activity. |
| priorityDate | 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.